| Financial Year |
June 30 2021 |
| Monetary Funds |
728,889,524.85 |
| Held-for-trading Financial Assets |
706,229,739.51 |
| Notes Receivable |
15,316,708.54 |
| Accounts Receivable |
101,858,070.72 |
| Advances to Suppliers |
4,430,666.00 |
| Other Receivables |
43,994,660.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,767,629,000.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
255,988,694.49 |
| Total Current Assets |
3,624,337,065.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
21,760,206.66 |
| Fixed Assetes |
175,189,858.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,393,045.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,910,877.97 |
| Deferred Income Tax Assets |
4,504,193.34 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
394,041,323.66 |
| Total Assets |
4,018,378,389.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
987,714,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
117,776,122.03 |
| Accounts Received In Advance |
1,718,026.57 |
| Employee Compensation Payable |
22,412,736.77 |
| Taxes Payable |
83,795,911.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,099,673.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,609,034,916.71 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,281,551.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
111,209,737.39 |
| Total Liabilities |
1,720,244,654.10 |
| Paid-In Capital(Or Share Stock) |
700,000,000.00 |
| Capital Surplus |
186,307,435.84 |
| Surplus Reserve |
622,135,912.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
682,522,260.15 |
| Minority Stockholder's Interest |
11,095,777.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,287,037,956.96 |
| Owner's Equity（Stockholder's Equity） |
2,298,133,734.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,018,378,389.05 |
